Vanguard Group
STTK icon

Vanguard Group’s Shattuck Labs STTK Stock Holding History

Vanguard Group’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.68M Buy
2,377,746
+249,345
+12% +$595K ﹤0.01% 3032
2025
Q3 		$5.09M Sell
2,128,401
-19,773
-0.9% -$24.2K ﹤0.01% 3281
2025
Q2 		$1.7M Sell
2,148,174
-252,364
-11% -$245K ﹤0.01% 3588
2025
Q1 		$2.28M Sell
2,400,538
-7,916
-0.3% -$9.75K ﹤0.01% 3456
2024
Q4 		$2.91M Buy
2,408,454
+6,545
+0.3% +$8.11K ﹤0.01% 3452
2024
Q3 		$8.38M Buy
2,401,909
+98,909
+4% +$369K ﹤0.01% 3046
2024
Q2 		$8.89M Buy
2,303,000
+483,074
+27% +$3.93M ﹤0.01% 2993
2024
Q1 		$16.3M Buy
1,819,926
+502,860
+38% +$4.61M ﹤0.01% 2699
2023
Q4 		$9.39M Buy
1,317,066
+143,332
+12% +$391K ﹤0.01% 2979
2023
Q3 		$1.78M Buy
1,173,734
+5,138
+0.4% +$11.7K ﹤0.01% 3627
2023
Q2 		$3.65M Sell
1,168,596
-6,525
-0.6% -$18.9K ﹤0.01% 3446
2023
Q1 		$3.45M Buy
1,175,121
+11,040
+0.9% +$39K ﹤0.01% 3474
2022
Q4 		$2.68M Buy
1,164,081
+13,331
+1% +$33.4K ﹤0.01% 3559
2022
Q3 		$3.11M Hold
1,150,750
– – ﹤0.01% 3571
2022
Q2 		$4.67M Sell
1,150,750
-196,599
-15% -$712K ﹤0.01% 3413
2022
Q1 		$5.74M Sell
1,347,349
-91,893
-6% -$521K ﹤0.01% 3463
2021
Q4 		$12.2M Buy
1,439,242
+8,707
+0.6% +$120K ﹤0.01% 3111
2021
Q3 		$29.2M Buy
1,430,535
+197,549
+16% +$4.23M ﹤0.01% 2654
2021
Q2 		$35.7M Buy
1,232,986
+544,808
+79% +$15.9M ﹤0.01% 2543
2021
Q1 		$20.1M Buy
688,178
+7,811
+1% +$328K ﹤0.01% 2781
2020
Q4 		$35.7M Buy
+680,367
New +$21.9M ﹤0.01% 2369

Other funds holding STTK

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Vanguard Group's STTK Position: Q4 2025 in Review

Vanguard Group increased its Shattuck Labs (STTK) stake by 12% in Q4 2025, buying an estimated $595K and bringing the position to 2,377,746 shares worth $8.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

Vanguard Group first reported a position in STTK in Q4 2020 and has held it in 21 quarters since. The position peaked at $35.7M in Q2 2021. 65 funds tracked by Wall St. Rank hold STTK as of Q4 2025.

  • Vanguard Group held 2,377,746 shares of Shattuck Labs worth $8.68M as of Q4 2025.
  • Vanguard Group bought 249,345 Shattuck Labs shares in Q4 2025, an estimated $595K.
  • Shattuck Labs made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3032 holding.
  • Vanguard Group first reported a position in Shattuck Labs in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's Shattuck Labs position peaked at $35.7M in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Shattuck Labs as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.